LLMpediaThe first transparent, open encyclopedia generated by LLMs

Stevenson-Wydler Technology Innovation Act

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 46 → Dedup 20 → NER 9 → Enqueued 8
1. Extracted46
2. After dedup20 (None)
3. After NER9 (None)
Rejected: 11 (not NE: 11)
4. Enqueued8 (None)
Similarity rejected: 1
Stevenson-Wydler Technology Innovation Act
ShorttitleStevenson-Wydler Technology Innovation Act
LongtitleAn Act to promote technology transfer of federally funded research and development, to authorize cooperative research and development agreements, and for other purposes.
Enacted by96th
Effective dateOctober 15, 1980
Cite public law96-480
IntroducedinHouse
IntroducedbyRep. John Wydler (R-NY)
CommitteesHouse Science and Technology Committee
Passedbody1House
Passedbody2Senate
SignedpresidentJimmy Carter
SigneddateOctober 15, 1980

Stevenson-Wydler Technology Innovation Act is a foundational United States federal law enacted in 1980 to accelerate the commercialization of federally funded research. Sponsored by Senator Adlai Stevenson III and Representative John Wydler, the legislation was a direct response to concerns over U.S. economic competitiveness, particularly against nations like Japan and West Germany. It established the first formal policy requiring federal laboratories to actively transfer their technological developments to the private sector, state governments, and local governments.

Background and legislative history

The impetus for the act grew from widespread anxiety in the late 1970s about declining American industrial productivity and innovation, often termed "deindustrialization." Studies, including a report by the White House Office of Science and Technology Policy, highlighted that billions of dollars in research at agencies like the Department of Defense and the Department of Energy were not reaching commercial markets. Key figures such as Senator Adlai Stevenson III and Congressman John Wydler championed the bill, arguing that federal R&D was a national resource being underutilized. The legislation faced debates over the role of government in commerce but gained bipartisan support, ultimately being signed into law by President Jimmy Carter on October 15, 1980, as part of a broader push that included the Bayh–Dole Act.

Key provisions and mechanisms

The act mandated that every major federal agency with a significant research budget establish an Office of Research and Technology Application (ORTA) to identify and promote technologies with commercial potential. It required laboratories to dedicate a percentage of their budgets to these technology transfer activities. A central provision allowed federal laboratories to enter into Cooperative Research and Development Agreements (CRADAs) with private companies, universities, and other entities, permitting the sharing of personnel, equipment, and intellectual property. Furthermore, it led to the creation of the National Technical Information Service as a central repository for federal research findings and established the Federal Laboratory Consortium for Technology Transfer to facilitate networking among labs.

Implementation and administration

Primary responsibility for oversight was assigned to the Secretary of Commerce, acting through agencies like the National Institute of Standards and Technology (NIST). The Federal Laboratory Consortium, headquartered at the National Technology Transfer Center, became a key vehicle for coordination. Major implementing agencies included the Department of Energy, the National Aeronautics and Space Administration (NASA), the National Institutes of Health (NIH), and the Department of Defense. Each agency developed its own policies and patent agreements in accordance with the framework, with ORTA personnel acting as liaisons between scientists and potential industrial partners in sectors like biotech, materials science, and computing.

Impact and legacy

The act is widely credited with transforming the culture of federal labs, making technology transfer a core mission alongside basic research. It facilitated thousands of CRADAs, leading to notable commercial products and spin-off companies in fields such as medical devices, environmental remediation, and telecommunications. Subsequent analysis by organizations like the Government Accountability Office and the National Academies of Sciences, Engineering, and Medicine has shown it significantly increased collaboration between public research institutions and private industry. Its framework directly inspired similar policies in states and other countries, cementing the model of active knowledge transfer from public science to the marketplace.

The act has been amended several times to strengthen its provisions. The most significant amendment was the Federal Technology Transfer Act of 1986, which explicitly authorized CRADAs and allowed government scientists to receive royalty payments. This was followed by the National Competitiveness Technology Transfer Act of 1989, which extended CRADA authority to government-owned, contractor-operated (GOCO) labs like those managed by Battelle Memorial Institute. Other key related laws include the Bayh–Dole Act, which allowed universities and small businesses to retain title to inventions from federally funded research, and the Small Business Innovation Development Act, creating the Small Business Innovation Research (SBIR) program. Together, these laws form the cornerstone of modern U.S. innovation policy.

Category:United States federal technology legislation Category:1980 in American law Category:Research and development in the United States